Aura Biosciences Inc at JMP Securities Life Sciences Conference Transcript
Good afternoon, everybody. My name is John Wolleben, Senior Analyst at JMP Securities. I'm pleased to have Aura Biosciences joining us, and CEO Eli de los Pinos. Thanks, Eli, for coming and joining with us. It's been an exciting, I think, year and a half or so since we've launched coverage on you guys. And I've been excited seeing all the new data. And I'm excited to talk more about the opportunity in choroidal melanoma and everything else you have in the pipeline. So thanks again for coming today.
Yeah, it's a pleasure. Thank you, John, for inviting us.
Questions & Answers
And are we going to use AU-011 or Bel-Sar today to talk?
I think we're going to use Bel-Sar.
All right, we're making the transition as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
